Estradiol/dydrogesterone
Estradiol/dydrogesterone (E2/DYD), sold under the brand name Femoston among others, is a combination of estradiol (E2), an estrogen, and dydrogesterone (DYD), a progestin, which is used in menopausal hormone therapy, specifically to treat and prevent hot flashes and osteoporosis, in postmenopausal women. It is taken by mouth and contains 0.5, 1, or 2 mg E2 and 2.5, 5, 10, or 20 mg DYD per tablet. The medication is marketed widely throughout the world. It is not available in the United States or Canada.
Q1779868
combination
Concept
Q12415847
estradiol
Concept
Q48841284
estrogen
Concept
Q4161380
dydrogesterone
Concept
Q50383885
progestin
Concept
Q3354346
menopausal hormone therapy
Concept
Q1858291
hot flash
Concept
Q165328
osteoporosis
Concept
Q177708
postmenopausal
Concept
Q285166
by mouth
Concept
Q206077
tablet
Concept
Q30
United States
LOC
Q16
Canada
LOC
Q85759677
Estradiol/dydrogesterone
Concept
2020-05-10T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
5, 10
DATE
+2^^http://www.w3.org/2001/XMLSchema#decimal
2
NUMBER
+2^^http://www.w3.org/2001/XMLSchema#decimal
2
NUMBER
+0.5^^http://www.w3.org/2001/XMLSchema#decimal
0.5
NUMBER
+1^^http://www.w3.org/2001/XMLSchema#decimal
1
NUMBER
+2^^http://www.w3.org/2001/XMLSchema#decimal
2
NUMBER
+2^^http://www.w3.org/2001/XMLSchema#decimal
2
NUMBER
+2.5^^http://www.w3.org/2001/XMLSchema#decimal
2.5
NUMBER
+20^^http://www.w3.org/2001/XMLSchema#decimal
20
NUMBER
instance of
part of
medical condition treated